Print

Zogenix, Inc. to Present at the 24th Annual Piper Jaffray Healthcare Conference  
11/15/2012 7:31:45 AM

SAN DIEGO, Nov. 15, 2012 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain, today announced that Roger L. Hawley, Chief Executive Officer, and Ann Rhoads, Executive Vice President and Chief Financial Officer, will be presenting at the 24th Annual Piper Jaffray Healthcare Conference on November 28, 2012 in New York City.
//-->